Viewing Study NCT05024318


Ignite Creation Date: 2025-12-25 @ 4:29 AM
Ignite Modification Date: 2025-12-26 @ 3:32 AM
Study NCT ID: NCT05024318
Status: RECRUITING
Last Update Posted: 2024-05-16
First Post: 2021-03-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma
Sponsor: Peter MacCallum Cancer Centre, Australia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module